The Role of STEMI Communication Network in Malang with Major Adverse Cardiac Event (MACE) Incidence in STEMI Patients Hospitalized in Saiful Anwar General Hospital Malang

Authors

  • Adhika Prastya Wikananda Universitas Brawijaya
  • Lenny Kartika Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya-Dr. Saiful Anwar General Hospital, Malang East Java, Indonesia
  • Dadang Hendrawan Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya-Dr. Saiful Anwar General Hospital, Malang East Java, Indonesia
  • Heny Martini Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya-Dr. Saiful Anwar General Hospital, Malang East Java, Indonesia
  • Mohammad Saifur Rohman Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya-Dr. Saiful Anwar General Hospital, Malang East Java, Indonesia

DOI:

https://doi.org/10.21776/ub.hsj.2021.002.04.3

Keywords:

STEMI, reperfusion network, MACE

Abstract

Background: Patient with STEMI requires urgent reperfusion either with fibrinolytic or primary PCI. In Malang, a communication network of STEMI has been developed. It connects Saiful Anwar General Hospital with all of the PHC in Greater Malang to shorten system delay since 2015.

Objective: To elucidate Malang’s communication network’s role in decreasing MACE (Major Adverse Cardiac Event) in STEMI patients.

Methods : This is a retrospective cohort study. Study sample was taken from medical record. Non-network: 96 patients and 88 network patients. Statistical tests using SPSS and PLS, α value 0.05 and t-test is significant if more than 1.96.

Results: Bivariate analysis shows network-group has a significantly lower MACE (p=0.001). Door-to-balloon time is also lower in network-group (p=0.026). Multivariate analysis without confounder shows that network-group has significantly shorter door-to-reperfusion time (p=0.032) and lower MACE (p=0.035) compared to non-network group. But multivariate analysis with confounder door-to-balloon and door-to-needle fails to explain lower MACE incidence. Network-group (p=0.005) and reperfusion with primary PCI (p=0.05) significantly decrease MACE incidence.

Conclusion: Malang’s STEMI communication network and reperfusion with primary PCI reduce MACE in STEMI patients in Saiful Anwar General Hospital Malang.

References

Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan;125(1):e2-20.

Penelitian B. Riset kesehatan dasar (Riskesdas) 2013. Lap Nas. 2013;2013(1):384.

Deopujari, R., Dixit, A. The Study of Age Related Changes in Coronary Arteries and its Relevance to the Atherosclerosis. J Anat Soc India, 2010 59(2):192-196

Soliman EZ, Lopez F, O’Neal WT, Chen LY, Bengtson L, Zhang ZM, Loehr L, Cushman M, Alonso A. Atrial fibrillation and risk of ST-segment–elevation versus non–ST-segment–elevation myocardial infarction: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015 May 26;131(21):1843-50.

Topol E, Califf R, Prystowsky E, et al. Textbook of Cardiovascular Medicine. 2007; 19:280-303

WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. Journal of clinical epidemiology. 1988 Jan 1;41(2):105-14.

Alexander T, Victor SM, Mullasari AS, Veerasekar G, Subramaniam K, Nallamothu BK, TN-STEMI Programme Investigators. Protocol for a prospective, controlled study of assertive and timely reperfusion for patients with ST-segment elevation myocardial infarction in Tamil Nadu: the TN-STEMI programme. BMJ open. 2013 Dec 1;3(12):e003850.

Bonnefoy E, Steg PG, Boutitie F, Dubien PY, Lapostolle F, Roncalli J, Dissait F, Vanzetto G, Leizorowicz A, Kirkorian G, CAPTIM Investigators. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. European heart journal. 2009 May 8;30(13):1598-606.

Downloads

Published

2021-10-31

Issue

Vol. 2 No. 4 (2021): Management of Thrombosis in Covid-19 Patient with Cardiovascular Disease

Section

Original Article

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).